These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 28938268)

  • 1. Surgical and Survival Outcomes Following Pelvic Exenteration for Locally Advanced Primary Rectal Cancer: Results From an International Collaboration.
    PelvEx Collaborative
    Ann Surg; 2019 Feb; 269(2):315-321. PubMed ID: 28938268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer.
    PelvEx Collaborative
    Br J Surg; 2018 May; 105(6):650-657. PubMed ID: 29529336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total pelvic exenteration for primary and recurrent malignancies.
    Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
    World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer.
    Bhangu A; Ali SM; Brown G; Nicholls RJ; Tekkis P
    Ann Surg; 2014 Feb; 259(2):315-22. PubMed ID: 23478530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer.
    PelvEx Collaborative
    BJS Open; 2019 Aug; 3(4):516-520. PubMed ID: 31388644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of survival following pelvic exenteration for primary rectal cancer.
    Radwan RW; Jones HG; Rawat N; Davies M; Evans MD; Harris DA; Beynon J;
    Br J Surg; 2015 Sep; 102(10):1278-84. PubMed ID: 26095525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary results from the PelvEx collaborative: improvements in surgical outcomes for locally advanced and recurrent rectal cancer.
    PelvEx Collaborative
    Colorectal Dis; 2024 May; 26(5):926-931. PubMed ID: 38566456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma.
    Gannon CJ; Zager JS; Chang GJ; Feig BW; Wood CG; Skibber JM; Rodriguez-Bigas MA
    Ann Surg Oncol; 2007 Jun; 14(6):1870-7. PubMed ID: 17406945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pelvic exenteration and composite sacral resection in the surgical treatment of locally recurrent rectal cancer.
    Gawad W; Khafagy M; Gamil M; Fakhr I; Negm M; Mokhtar N; Lotayef M; Mansour O
    J Egypt Natl Canc Inst; 2014 Sep; 26(3):167-73. PubMed ID: 25150132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous pelvic exenteration and liver resection for primary rectal cancer with synchronous liver metastases: results from the PelvEx Collaborative.
    PelvEx Collaborative
    Colorectal Dis; 2020 Oct; 22(10):1258-1262. PubMed ID: 32294308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer.
    Platt E; Dovell G; Smolarek S
    Tech Coloproctol; 2018 Nov; 22(11):835-845. PubMed ID: 30506497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelvic exenteration for men with locally advanced rectal cancer: a morbidity analysis of complicated cases.
    Hsu TW; Chiang FF; Chen MC; Wang HM
    Asian J Surg; 2011 Jul; 34(3):115-20. PubMed ID: 22208686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of pelvic exenteration for recurrent and primary locally advanced rectal cancer.
    Rottoli M; Vallicelli C; Boschi L; Poggioli G
    Int J Surg; 2017 Dec; 48():69-73. PubMed ID: 28987560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pelvic Exenteration for Advanced Nonrectal Pelvic Malignancy.
    PelvExCollaborative
    Ann Surg; 2019 Nov; 270(5):899-905. PubMed ID: 31634184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer.
    Yamada K; Ishizawa T; Niwa K; Chuman Y; Aikou T
    Dis Colon Rectum; 2002 Aug; 45(8):1078-84. PubMed ID: 12195193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does radiotherapy of the primary rectal cancer affect prognosis after pelvic exenteration for recurrent rectal cancer?
    Rombouts AJ; Koh CE; Young JM; Masya L; Roberts R; De-Loyde K; de Wilt JH; Solomon MJ
    Dis Colon Rectum; 2015 Jan; 58(1):65-73. PubMed ID: 25489696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies.
    Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD; Austin KK
    Dis Colon Rectum; 2014 Oct; 57(10):1153-61. PubMed ID: 25203370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic Review of Pelvic Exenteration With En Bloc Sacrectomy for Recurrent Rectal Adenocarcinoma: R0 Resection Predicts Disease-free Survival.
    Sasikumar A; Bhan C; Jenkins JT; Antoniou A; Murphy J
    Dis Colon Rectum; 2017 Mar; 60(3):346-352. PubMed ID: 28177998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Urinary complications of pelvic exenterations for rectal cancer with urinary invasion].
    Gas J; Beauval JB; Chalret du Rieu M; Bou Nasr E; Philis A; Kirzin S; Thoulouzan M; SouliƩ M; Ghouti L
    Prog Urol; 2015 May; 25(6):348-54. PubMed ID: 25804429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Pelvic Exenteration with en Bloc Partial or Complete Pubic Bone Excision for Locally Advanced Primary or Recurrent Pelvic Cancer.
    Austin KK; Herd AJ; Solomon MJ; Ly K; Lee PJ
    Dis Colon Rectum; 2016 Sep; 59(9):831-5. PubMed ID: 27505111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.